http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-9304140-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76195fd1cd08192222699d8e7a88c231
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
filingDate 1993-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea07c8b76715161258a8a60dcab923bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f328ee2c5a23ccb3d32e09b14c1d8a8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_506fac026de18a98b89d9d2a82f4f9d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0263c60a9df2106874df5f2f21841bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a8784228b0e41d8e25be75b84bc9437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d024111dbda291f6cf93231c8a1a911
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_390b63a730dd36aac4caa8b58dcbbd2a
publicationDate 1994-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-9304140-A
titleOfInvention PURINE SALT, PROCESS FOR ITS PREPARATION AND PROCESS FOR PREPARING AN ANTIVIRAL AGENT THROUGH THE REACTION OF SUCH SALT.
abstract A purine salt of the formula is described: wherein Y1 is chlorine, bromine, or iodine, and R1, R2, R3, and R4 are independently selected from alkyl and substituted alkyl, the salt is reacted with the compound of the formula to produce the purine of the formula: where X is a leaving group, and Z1 is a protected form of the Z carbohydrate substitute. Several routes are described for the conversion of this intermediate to the antiviral agent.
priorityDate 1992-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410062813

Total number of triples: 34.